Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)72

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)18

Views

Views
September 20252
October 20251
November 20256
December 20252
January 20263
February 20262
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil5
Mexico2
Argentina1
Algeria1
Turkey1
 

Top cities views

Views
Ashburn3
San Jose2
Campo Grande1
Chimbas1
Chlef1
Criciúma1
Dallas1
Erechim1
Istanbul1
Juazeiro1